Primary Record
proscillaridin
- In stock
- 7,233 g
- Purity
- 99.5 %
- CAS
- 466-06-8
Compound Identifiers & Properties
- CAS
- 466-06-8
- PubChem CID
- 222154
- SMILES
- CC1C(C(C(C(O1)O[C@H]2CC[C@@]3([C@H]4CC[C@@]5([C@H](CC[C@@]5([C@@H]4CCC3=C2)O)C6=COC(=O)C=C6)C)C)O)O)O
- Canonical SMILES
- CC1OC(O[C@@H]2C=C3CC[C@@H]4[C@H](CC[C@]5(C)[C@@H](c6ccc(=O)oc6)CC[C@]45O)[C@@]3(C)CC2)C(O)C(O)C1O
Names & Synonyms
- proscillaridin
- Caradrine
- Caradrin
- Proscillaridin A
- Proscillaridine
- Cardiovite
- Proscillan
- Proslladin
- Sandoscill
- Scillacrist
- Carmazon
- Procardin
- Procilan
- Prostosin
- Protasin
- Solestril
- Stellarid
- Tradenal
- Wirnesin
- Cardion
- Coratol
- Proszin
- Talusin
- Urgilan
- Simeon
- Herzo proscillan
- Proscillaridin-A
- Proscilardyna
- Proscilaridina
- Proscillaridina
- Talucard
- Purosin-TC
- Herzo
- Proscillaridinum
- Scilla didier
- Scilla "didier"
- Scilla "didie"
- Desglucotransvaaline
- Transvaalin, degluco-
- Desgluco-transvaalin
- Scillarenin-rhamnose
- Proscilardyna [Polish]
- Proscillaridina [DCIT]
- AC1L5BDR
- UNII-KC6BL281EN
- NSC7521
- Scillarenin 3beta-rhamnoside
- Proscilaridina [INN-Spanish]
- Proscillaridine [INN-French]
- Proscillaridinum [INN-Latin]
- Scillarenin 3-beta-rhamnoside
- Scillarenin-rhamnose [German]
- PSC-801
- Rhamnopyranoside, .alpha.-L-
- Scillarenin 3.beta.-rhamnoside
- SCHEMBL1649544
- CHEMBL1977418
- KST-1A5746
- C30H42O8
- NSC 7521
- NSC-7521
- EINECS 207-370-4
- AR-1A4874
- CID222154
- Proscillaridin [USAN:BAN:INN:JAN]
- Proscillaridin [USAN:INN:BAN:JAN]
- Scillarenin, 3alpha-L-rhamnopyranoside
- C30-H42-O8
- HBL0000188
- Scillarenin, 3-alpha-L-rhamnopyranoside
- A-32686
- NCI60_041645
- PD011571
- Scillarenin, 3.alpha.-L-rhamnopyranoside
- Rhamnopyranoside, scillarenin-3, alpha-L-
- NS00007846
- P8334
- 466-06-8
- 14-Hydroxy-3.beta.-(rhamnosyloxy)bufa-4,22-trienolide
- 14-Hydroxy-3-beta-(rhamnosyloxy)bufa-4,20,22-trienolide
- 14-Hydroxy-3beta-(rhamnosyloxy)bufa-4,20,22-trienolide
- Desgluco-transvaalin3.beta.,20,22-trienolide 3-rhamnoside
- (3|A)-3-[(6-deoxyhexopyranosyl)oxy]-14-hydroxybufa-4,20,22-trienolide
- 3-beta,14-beta-Dihydroxybufa-4,20,22-trienolide 3-rhamnoside
- 5-[(3S,8R,9S,10R,13R,14S,17R)-14-hydroxy-10,13-dimethyl-3-(3,4,5-trihydroxy-6-methyloxan-2-yl)oxy-1,2,3,6,7,8,9,11,12,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl]pyran-2-one
- ((6-Deoxy-alpha-L-mannopyranosyl)oxy)-14-hydroxybufa-4,20,22-trienolide
- (3Beta)-3-[(6-deoxyhexopyranosyl)oxy]-14-hydroxybufa-4,20,22-trienolide
- [(6-Deoxy-.alpha.-L-mannopyranosyl)oxy]-14-hydroxybufa-4,22-trienolide
- 3-beta-Rhamnosido-14-beta-hydroxy-delta(sup 4,20,22)-bufatrienolide
- 3.beta.-Rhamnosido-14.beta.-hydroxy-.delta.(sup 4,22)-bufatrienolide
- 5436-96-4
- WLN: L E5 B666 MUTJ A1 E1 IQ F- ET6OVJ& O- BT6OTJ CQ DQ EQ F1
- (3-beta)-3-[(6-Deoxy-alpha-L-mannopyranosyl)oxy]-14-hydroxybufa-4,20,22-trienolide
- 3-beta-((6-Deoxy-alpha-L-mannopyranosyl)oxy)-14-hydroxybufa-4,20,22-trienolide
- Bufa-4,20,22-trienolide, 3-((6-deoxy-alpha-L-mannopyranosyl)oxy)-14-hydroxy-, (3-beta)-
- Bufa-4,20,22-trienolide, 3-((6-deoxy-alpha-L-mannopyranosyl)oxy)-14-hydroxy-, (3beta)-
- Bufa-4,20,22-trienolide, 3-beta-((6-deoxy-alpha-L-mannosyl)oxy)-14-hydroxy-
- Bufa-4,22-trienolide, 3-[(6-deoxy-.alpha.-L-mannopyranosyl)oxy]-14-hydroxy-, (3.beta.)-
- Bufa-4,22-trienolide, 3.beta.-[(16-deoxy-.alpha.-L-mannosyl)oxy]-14-hydroxy-
- Bufa-4,22-trienolide, 3.beta.-[(6-deoxy-.alpha.-L-mannopyranosyl)oxy]-14-hydroxy-
- 12041-88-2
- 5-[(3S,8R,9S,10R,13R,14S,17R)-14-hydroxy-10,13-dimethyl-3-(3,4,5-trihydroxy-6-methyl-tetrahydropyran-2-yl)oxy-1,2,3,6,7,8,9,11,12,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl]pyran-2-one